GCMG
CVS icon

Gyroscope Capital Management Group’s CVS Health CVS Stock Holding History

Gyroscope Capital Management Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$10.5M Buy
150,961
+9,398
+7% +$666K 2.42% 5
2023
Q2 		$9.79M Buy
141,563
+25,729
+22% +$1.83M 2.26% 11
2023
Q1 		$8.61M Buy
115,834
+11,280
+11% +$946K 2.19% 16
2022
Q4 		$9.74M Buy
104,554
+5,479
+6% +$529K 2.95% 3
2022
Q3 		$9.45M Buy
99,075
+5,561
+6% +$550K 3.65% 1
2022
Q2 		$8.66M Buy
93,514
+7,822
+9% +$763K 2.98% 4
2022
Q1 		$8.67M Sell
85,692
-9,334
-10% -$981K 2.98% 5
2021
Q4 		$9.8M Sell
95,026
-367
-0.4% -$33.9K 3.45% 4
2021
Q3 		$8.1M Buy
95,393
+2,394
+3% +$201K 3.06% 4
2021
Q2 		$7.76M Sell
92,999
-295
-0.3% -$24.2K 2.73% 8
2021
Q1 		$7.02M Buy
93,294
+363
+0.4% +$26.4K 2.81% 8
2020
Q4 		$6.35M Sell
92,931
-2,912
-3% -$189K 2.73% 8
2020
Q3 		$5.6M Sell
95,843
-724
-0.7% -$45K 2.54% 10
2020
Q2 		$6.27M Sell
96,567
-27,171
-22% -$1.71M 2.85% 7
2020
Q1 		$7.34M Sell
123,738
-2,718
-2% -$181K 3.45% 8
2019
Q4 		$9.39M Sell
126,456
-17,964
-12% -$1.26M 3.39% 4
2019
Q3 		$8.84M Sell
144,420
-14,189
-9% -$841K 3.51% 4
2019
Q2 		$8.81M Buy
158,609
+32,810
+26% +$1.77M 3.32% 4
2019
Q1 		$6.82M Buy
125,799
+43,104
+52% +$2.66M 2.6% 20
2018
Q4 		$5.42M Sell
82,695
-31,237
-27% -$2.33M 2.07% 12
2018
Q3 		$8.96M Buy
113,932
+6,139
+6% +$439K 3.67% 3
2018
Q2 		$6.94M Buy
107,793
+6,115
+6% +$403K 3.07% 16
2018
Q1 		$6.33M Buy
101,678
+39,896
+65% +$2.86M 3.01% 16
2017
Q4 		$4.48M Sell
61,782
-12,541
-17% -$912K 2.05% 21
2017
Q3 		$6.04M Buy
74,323
+3,624
+5% +$287K 3.05% 7
2017
Q2 		$5.69M Buy
+70,699
New +$5.58M 2.84% 5
2016
Q4 		– Sell
-3,262
Closed -$290K – 105
2016
Q3 		$290K Buy
+3,262
New +$308K 0.22% 59

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gyroscope Capital Management Group's CVS Position: Q3 2023 in Review

Gyroscope Capital Management Group increased its CVS Health (CVS) stake by 6.6% in Q3 2023, buying an estimated $666K and bringing the position to 150,961 shares worth $10.5M. The position accounts for 2.42% of the portfolio, ranked #5.

Gyroscope Capital Management Group first reported a position in CVS in Q3 2016 and has held it in 27 quarters since. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Gyroscope Capital Management Group held 150,961 shares of CVS Health worth $10.5M as of Q3 2023.
  • Gyroscope Capital Management Group bought 9,398 CVS Health shares in Q3 2023, an estimated $666K.
  • CVS Health made up 2.42% of Gyroscope Capital Management Group's portfolio in Q3 2023, its #5 holding.
  • Gyroscope Capital Management Group first reported a position in CVS Health in Q3 2016 and has held it in 27 quarters since.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2023, filed 13 Nov 2023.